Bank of New York Mellon’s VolitionRx Ltd VNRX Stock Holding History

Bank of New York Mellon’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,780	Closed	-$11.2K	–	4439
2026 Q1	$11.2K	Hold	2,780	–	–	﹤0.01%	4185
2025 Q4	$14.2K	Buy	2,780 +1,250	+82%	+$9.49K	﹤0.01%	4173
2025 Q3	$20.8K	Hold	1,530	–	–	﹤0.01%	4160
2025 Q2	$23.3K	Hold	1,530	–	–	﹤0.01%	4108
2025 Q1	$17.4K	Buy	+1,530	New	+$18.2K	﹤0.01%	4093
2024 Q1	–	Sell	-1,047	Closed	-$15K	–	4319
2023 Q4	$15K	Sell	1,047 -11	-1%	-$162	﹤0.01%	4253
2023 Q3	$14.6K	Sell	1,058 -19	-2%	-$470	﹤0.01%	4272
2023 Q2	$29.9K	Sell	1,077 -4	-0.4%	-$132	﹤0.01%	4242
2023 Q1	$41.3K	Hold	1,081	–	–	﹤0.01%	4225
2022 Q4	$52.6K	Sell	1,081 -6	-0.6%	-$233	﹤0.01%	4229
2022 Q3	$30K	Hold	1,087	–	–	﹤0.01%	4397
2022 Q2	$45K	Sell	1,087 -4	-0.4%	-$201	﹤0.01%	4367
2022 Q1	$66K	Hold	1,091	–	–	﹤0.01%	4481
2021 Q4	$69K	Hold	1,091	–	–	﹤0.01%	4457
2021 Q3	$68K	Sell	1,091 -27	-2%	-$1.71K	﹤0.01%	4392
2021 Q2	$74K	Sell	1,118 -3,380	-75%	-$229K	﹤0.01%	4266
2021 Q1	$340K	Buy	4,498 +202	+5%	+$17.3K	﹤0.01%	3857
2020 Q4	$334K	Buy	4,296 +441	+11%	+$30.4K	﹤0.01%	3786
2020 Q3	$248K	Sell	3,855 -12	-0.3%	-$816	﹤0.01%	3776
2020 Q2	$301K	Buy	3,867 +2,549	+193%	+$184K	﹤0.01%	3690
2020 Q1	$82K	Sell	1,318 -13	-1%	-$1.08K	﹤0.01%	3893
2019 Q4	$126K	Sell	1,331 -68	-5%	-$7.05K	﹤0.01%	3993
2019 Q3	$157K	Hold	1,399	–	–	﹤0.01%	3953
2019 Q2	$88K	Hold	1,399	–	–	﹤0.01%	4046
2019 Q1	$91K	Sell	1,399 -47	-3%	-$2.62K	﹤0.01%	4018
2018 Q4	$52K	Buy	1,446 +929	+180%	+$44.2K	﹤0.01%	4056
2018 Q3	$27K	Hold	517	–	–	﹤0.01%	4191
2018 Q2	$21K	Sell	517 -320	-38%	-$14.3K	﹤0.01%	4167
2018 Q1	$40K	Buy	837 +320	+62%	+$18.7K	﹤0.01%	4195
2017 Q4	$30K	Sell	517 -1,002	-66%	-$58.6K	﹤0.01%	4264
2017 Q3	$80K	Hold	1,519	–	–	﹤0.01%	4036
2017 Q2	$108K	Buy	1,519 +971	+177%	+$70K	﹤0.01%	4013
2017 Q1	$45K	Buy	548 +31	+6%	+$2.74K	﹤0.01%	4150
2016 Q4	$47K	Buy	+517	New	+$46.4K	﹤0.01%	4138
2016 Q3	–	Sell	-518	Closed	-$32K	–	4321
2016 Q2	$32K	Buy	518 +4	+0.8%	+$276	﹤0.01%	4238
2016 Q1	$36K	Hold	514	–	–	﹤0.01%	4119
2015 Q4	$46K	Hold	514	–	–	﹤0.01%	4199
2015 Q3	$46K	Buy	+514	New	+$39.5K	﹤0.01%	4253

Other funds holding VNRX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Bank of New York Mellon's VNRX Position: Q2 2026 in Review

Bank of New York Mellon sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 2,780 shares — an estimated $11.2K sold.

Bank of New York Mellon first reported a position in VNRX in Q3 2015 and held it in 38 quarters. The position peaked at $340K in Q1 2021. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

Bank of New York Mellon reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
Bank of New York Mellon sold 2,780 VolitionRx Ltd shares in Q2 2026, an estimated $11.2K.
Bank of New York Mellon first reported a position in VolitionRx Ltd in Q3 2015 and held it in 38 quarters.
Bank of New York Mellon's VolitionRx Ltd position peaked at $340K in Q1 2021.
19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.